TY - JOUR
T1 - Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment
AU - Resnick, Barbara
AU - Kolanowski, Ann
AU - Van Haitsma, Kimberly
AU - Galik, Elizabeth
AU - Boltz, Marie
AU - Ellis, Jeanette
AU - Behrens, Liza
AU - Eshraghi, Karen
AU - Zhu, Shijun
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by the National Institute of Nursing Research Grant Number: 1R01NR015982-01A1.
Publisher Copyright:
© The Author(s) 2019.
PY - 2021/1
Y1 - 2021/1
N2 - This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.
AB - This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.
UR - http://www.scopus.com/inward/record.url?scp=85063946956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063946956&partnerID=8YFLogxK
U2 - 10.1177/1054773819838678
DO - 10.1177/1054773819838678
M3 - Article
C2 - 30943786
AN - SCOPUS:85063946956
SN - 1054-7738
VL - 30
SP - 59
EP - 69
JO - Clinical Nursing Research
JF - Clinical Nursing Research
IS - 1
ER -